- Home
- SM vs CRL Comparison
SM vs CRL Comparison
Compare SM & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SM | CRL |
|---|---|---|
| Founded | 1908 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 8.6B |
| IPO Year | 1996 | 1999 |
Fundamental Metrics
Financial Performance| Metric | SM | CRL |
|---|---|---|
| Price | $27.47 | $184.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | $34.36 | ★ $198.27 |
| AVG Volume (30 Days) | ★ 3.9M | 758.4K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.56% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,154,000,000.00 | $1,857,601,000.00 |
| Revenue This Year | $129.01 | N/A |
| Revenue Next Year | $6.29 | $3.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 17.24 | 10.48 |
| 52 Week Low | $17.45 | $144.26 |
| 52 Week High | $35.88 | $228.88 |
Technical Indicators
Market Signals| Indicator | SM | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 36.81 | 56.24 |
| Support Level | $26.98 | $147.26 |
| Resistance Level | $28.59 | $194.54 |
| Average True Range (ATR) | 1.42 | 6.91 |
| MACD | -0.63 | -0.29 |
| Stochastic Oscillator | 11.98 | 65.31 |
Price Performance
Historical ComparisonAbout SM SM Energy Company
SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. The Company operates in the oil and gas extraction industry, focused on exploration and production activities, onshore in the United States. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.